Why Female Health Is Poised to Outperform

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, female condom maker Female Health has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Female Health and see what CAPS investors are saying about the stock right now.

Female Healthfacts

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 97% of the 333 members who have rated Female Health believe the stock will outperform the S&P 500 going forward.

Just last week, one of those Fools, All-Star BKITU, succinctly summed up the Female Health bull case for our community: "Decent financials, consumable product, lots of growth potential not only in industrializing countries, but in already-industrialized countries. That's a rare treat these days."

But while you can certainly make huge gains in exciting small-cap companies like Female Health, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

The article Why Female Health Is Poised to Outperform originally appeared on Fool.com.

Fool contributor Brian Pacampara has no position in any stocks mentioned, and neither does The Motley Fool. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.